| Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis AI Gomaa, SA Khan, MB Toledano, I Waked, SD Taylor-Robinson World journal of gastroenterology: WJG 14 (27), 4300, 2008 | 967 | 2008 |
| Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics MIF Shariff, IJ Cox, AI Gomaa, SA Khan, W Gedroyc, SD Taylor-Robinson Expert review of gastroenterology & hepatology 3 (4), 353-367, 2009 | 431 | 2009 |
| Diagnosis of hepatocellular carcinoma AI Gomaa, SA Khan, ELS Leen, I Waked, SD Taylor-Robinson World Journal of Gastroenterology: WJG 15 (11), 1301, 2009 | 280 | 2009 |
| Hepatitis C in Egypt–past, present, and future A Elgharably, AI Gomaa, MME Crossey, PJ Norsworthy, I Waked, ... International journal of general medicine, 1-6, 2016 | 242 | 2016 |
| Hepatitis C infection in Egypt: prevalence, impact and management strategies A Gomaa, N Allam, A Elsharkway, M El Kassas, I Waked Hepatic medicine: evidence and research, 17-25, 2017 | 217 | 2017 |
| Hepatitis C treatment: where are we now? NJ Burstow, Z Mohamed, AI Gomaa, MW Sonderup, NA Cook, I Waked, ... International journal of general medicine, 39-52, 2017 | 159 | 2017 |
| Recent advances in multidisciplinary management of hepatocellular carcinoma AI Gomaa, I Waked World journal of hepatology 7 (4), 673, 2015 | 119 | 2015 |
| Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma: a response‐based approach G Han, S Berhane, H Toyoda, D Bettinger, O Elshaarawy, AWH Chan, ... Hepatology 72 (1), 198-212, 2020 | 109 | 2020 |
| Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study MIF Shariff, AI Gomaa, IJ Cox, M Patel, HRT Williams, MME Crossey, ... Journal of proteome research 10 (4), 1828-1836, 2011 | 104 | 2011 |
| Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt AI Gomaa, MS Hashim, I Waked PloS one 9 (3), e90929, 2014 | 98 | 2014 |
| Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies C Estes, M Abdel‐Kareem, W Abdel‐Razek, E Abdel‐Sameea, M Abuzeid, ... Alimentary Pharmacology & Therapeutics 42 (6), 696-706, 2015 | 97 | 2015 |
| Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion I Waked, S Berhane, H Toyoda, SL Chan, N Stern, D Palmer, T Tada, ... British journal of cancer 116 (4), 448-454, 2017 | 81 | 2017 |
| Enhancing NK cell cytotoxicity by miR-182 in hepatocellular carcinoma MM Abdelrahman, IO Fawzy, AA Bassiouni, AI Gomaa, G Esmat, I Waked, ... Human immunology 77 (8), 667-673, 2016 | 52 | 2016 |
| Health: redefined OO Oleribe, O Ukwedeh, NJ Burstow, AI Gomaa, MW Sonderup, N Cook, ... Pan African medical journal 30 (1), 2018 | 51 | 2018 |
| Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor … RA Youness, MA Rahmoon, RA Assal, AI Gomaa, MT Hamza, I Waked, ... Growth Factors 34 (3-4), 128-140, 2016 | 49 | 2016 |
| MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R in hepatocellular carcinoma patients MA Rahmoon, RA Youness, AI Gomaa, MT Hamza, I Waked, ... Growth Factors 35 (2-3), 76-87, 2017 | 46 | 2017 |
| GES: a validated simple score to predict the risk of HCC in patients with HCV‐GT4‐associated advanced liver fibrosis after oral antivirals G Shiha, I Waked, R Soliman, M Elbasiony, A Gomaa, NNH Mikhail, ... Liver International 40 (11), 2828-2833, 2020 | 43 | 2020 |
| Aiming at the global elimination of viral hepatitis: challenges along the care continuum A Heffernan, E Barber, NA Cook, AI Gomaa, YX Harley, CR Jones, ... Open forum infectious diseases 5 (1), ofx252, 2018 | 36 | 2018 |
| Platelet-albumin-bilirubin score-a predictor of outcome of acute variceal bleeding in patients with cirrhosis O Elshaarawy, N Allam, E Abdelsameea, A Gomaa, I Waked World journal of hepatology 12 (3), 99, 2020 | 32 | 2020 |
| Effectiveness of ravidasvir plus sofosbuvir in interferon-naïve and treated patients with chronic hepatitis C genotype-4 G Esmat, T Elbaz, M El Raziky, A Gomaa, M Abouelkhair, HG El Deen, ... Journal of hepatology 68 (1), 53-62, 2018 | 32 | 2018 |
